Study in Patients With COPD

Dey Pharma

Status and phase: Completed; Phase 2

Conditions: COPD

Treatments: Drug: Formoterol Fumarate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00215384

DL-052

Details and patient eligibility

About

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

-History of COPD and cigarette smoking

Exclusion criteria

• Clinical diagnosis of asthma.
• Chest X-ray that is diagnostic of a significant pulmonary disease other than COPD
• Disease of other major organ systems

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind